Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

244
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
244
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

551
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
551
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

234
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
234

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Acquired erythroderma in adults].

Revue medicale suisse·2025
Same author

Efficacy of extracorporeal photopheresis in the treatment of severe erosive lichen planus: a case series.

Clinical and experimental dermatology·2025
Same author

Potential mogamulizumab-associated inflammatory bowel disease in cutaneous T-cell lymphoma management.

JAAD case reports·2024
Same author

[Dermatology. New uses for JAK inhibitors in dermatology: a panacea, but at what price?]

Revue medicale suisse·2024
Same author

Perforating Fibrous Histiocytoma Mimicking Keratoacanthoma: A Case Report.

Dermatopathology (Basel, Switzerland)·2024
Same author

[Vitiligo, no longer a fatality in 2023].

Revue medicale suisse·2023

Related Experiment Video

Updated: Feb 12, 2026

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
06:41

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse

Published on: October 24, 2018

13.0K

[Extracorporeal photopheresis].

Aurélie Hsieh1, Begonia Cortés1

  • 1Service de dermatologie et vénéréologie, HUG, 1211 Genève 14.

Revue Medicale Suisse
|March 29, 2018
PubMed
Summary

Extracorporeal photopheresis (ECP) uses ultraviolet light and a photosensitizer to treat various immune conditions. This review covers ECP

Area of Science:

  • Immunology
  • Dermatology
  • Transplantation

Background:

  • Extracorporeal photopheresis (ECP) is a therapeutic procedure involving ultraviolet A light and 8-methoxypsoralen.
  • Initially developed for cutaneous T-cell lymphoma, ECP has demonstrated efficacy in other immune-related disorders.
  • Despite its long-standing use in specialized centers, ECP remains unfamiliar to many physicians.

Purpose of the Study:

  • To review the practical aspects of performing ECP.
  • To elucidate the mechanism of action of ECP.
  • To outline the current clinical indications for ECP.

Main Methods:

  • Apheresis to collect white blood cells.
  • Incubation of collected cells with 8-methoxypsoralen.
  • Exposure of cells to ultraviolet A light.

More Related Videos

Author Spotlight: Effectiveness of Extracorporeal Shockwave Therapy in Achilles Tendinopathy Treatment
03:50

Author Spotlight: Effectiveness of Extracorporeal Shockwave Therapy in Achilles Tendinopathy Treatment

Published on: August 2, 2024

2.1K
Laparoscopic Extracorporeal Knot-Tying for Uterine Vessel Occlusion during Hysterectomy with Cervical Cerclage in Large Uteri
05:21

Laparoscopic Extracorporeal Knot-Tying for Uterine Vessel Occlusion during Hysterectomy with Cervical Cerclage in Large Uteri

Published on: September 12, 2025

518

Related Experiment Videos

Last Updated: Feb 12, 2026

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
06:41

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse

Published on: October 24, 2018

13.0K
Author Spotlight: Effectiveness of Extracorporeal Shockwave Therapy in Achilles Tendinopathy Treatment
03:50

Author Spotlight: Effectiveness of Extracorporeal Shockwave Therapy in Achilles Tendinopathy Treatment

Published on: August 2, 2024

2.1K
Laparoscopic Extracorporeal Knot-Tying for Uterine Vessel Occlusion during Hysterectomy with Cervical Cerclage in Large Uteri
05:21

Laparoscopic Extracorporeal Knot-Tying for Uterine Vessel Occlusion during Hysterectomy with Cervical Cerclage in Large Uteri

Published on: September 12, 2025

518

Main Results:

  • ECP shows efficacy in cutaneous T-cell lymphoma.
  • ECP is effective in managing graft-versus-host disease (acute and chronic).
  • ECP demonstrates utility in preventing transplant rejection (lung and cardiac) and treating autoimmune diseases.

Conclusions:

  • ECP is a valuable therapeutic option for various immune-mediated conditions.
  • Understanding ECP's practicalities, mechanism, and indications is crucial for broader clinical adoption.
  • Further dissemination of knowledge on ECP can improve patient outcomes in complex immune disorders.